SCHEMBL22309581

SCHEMBL22309581

Bc1ccc(C(=O)C(OC)(OC)c2ccc(B)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.62
HDAC1 Q13547 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
MLYCD O95822 3/20 0.35
MAPT P10636 2/20 0.34
SRC P12931 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33
APEX1 P27695 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SRD5A2 P31213 1/20 0.32
PLK1 P53350 1/20 0.32
CES2 O00748 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC11 Q96DB2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9800584 0.83 CES1 (0.65) CES1HDAC1CA2MAPTALDH1A1
SCHEMBL31208574 0.83 CES1 (0.65) CES1MAPTALDH1A1LMNAMAPK1
SCHEMBL13268944 0.83 CES1 (0.65) CES1CA1CA2MAPTALDH1A1
SCHEMBL11492544 0.81 CES1 (0.62) CES1HDAC1CA1CA2MAPT
SCHEMBL10816935 0.81 CES1 (0.62) CES1CA1CA2MAPTALDH1A1
SCHEMBL18790471 0.81 CES1 (0.62) CES1CA1CA2MLYCDMAPT
SCHEMBL10299600 0.81 CES1 (0.62) CES1CA1CA2MAPTALDH1A1
SCHEMBL275573 0.79 CES1 (0.59) CES1MAPTALDH1A1LMNAALOX15
SCHEMBL21784944 0.79 CES1 (0.59) CES1CA1CA2ALDH1A1LMNA
SCHEMBL16788942 0.79 CES1 (0.59) CES1HDAC1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247916-A1 BENZIL MONOKETALS AND THE USE THEREOF MERCK PATENT GMBH (DE) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247916-A1 BENZIL MONOKETALS AND THE USE THEREOF BCKDK, PKLR, BPHL CES1 1215/4885HDAC1 1998/4885CA1 3127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.